Literature DB >> 10588453

Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.

H I Thomas1, E Barrett, L M Hesketh, A Wynne, P Morgan-Capner.   

Abstract

BACKGROUND: A clinical diagnosis of rash-causing infections is not always possible and reliance has to be placed on serological evidence of infection, especially on the presence of specific immunoglobulin (Ig)M. However, despite the use of modern serological methods and validated commercial kits, reports appear in the literature of simultaneous IgM reactivity against more than one virus in cases of Epstein Barr virus, rubella, cytomegalovirus, human parvovirus B19 (HPV B19) and measles infections, all with implications for the pregnant woman.
OBJECTIVES: We decided to evaluate the extent of the problem in rubella, measles and HPV B19 infections in a routine diagnostic laboratory. STUDY
DESIGN: We tested sera from cases with initial clinical and serological evidence of infection with measles, HPV B19 or rubella for evidence of simultaneous IgM reactivity against more than one virus. We confirmed primary infections with specific-IgG antibody avidity tests, and subjected sera with IgM reactivity against more than one virus to avidity tests to identify which, if any, of the three viruses was the cause of the primary infection. Groups of monoreactive IgM sera were randomly selected from the presented sera to demonstrate that the avidity of the IgG specific for the other two viruses would be of high avidity compared with the low avidity of the IgG specific for the virus against which specific IgM had been detected.
RESULTS: Our results confirm that simultaneous IgM reactivity against more than one virus does occur in these three infections, and that this is unlikely to be caused by the presence of rheumatoid factor.
CONCLUSIONS: In the absence of seroconversion, reliance on specific IgM results alone for diagnosis of these infections should be avoided and tests such as specific IgG antibody avidity should also be employed. The simultaneous occurrence of IgM reactivity against more than one virus is also important for epidemiological and surveillance reasons as the widespread use of the mumps, measles and rubella vaccine makes its impact on the population. Falsely diagnosed cases of apparent measles or rubella could throw into question the efficacy of the vaccine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588453     DOI: 10.1016/s1386-6532(99)00051-7

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  20 in total

Review 1.  Interpretation of rubella serology in pregnancy--pitfalls and problems.

Authors:  Jennifer M Best; Siobhan O'Shea; Graham Tipples; Nicholas Davies; Saleh M Al-Khusaiby; Amanda Krause; Louise M Hesketh; Li Jin; Gisela Enders
Journal:  BMJ       Date:  2002-07-20

2.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Humoral immune response after primary rubella virus infection and after vaccination.

Authors:  C Vauloup-Fellous; L Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

4.  Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles.

Authors:  Antonio Sampedro; Javier Rodríguez-Granger; Cristina Gómez; Ana Lara; José Gutierrez; Ana Otero
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

5.  Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.

Authors:  Peter A C Maple; Lea Hedman; Pravesh Dhanilall; Kalle Kantola; Visa Nurmi; Maria Söderlund-Venermo; Kevin E Brown; Klaus Hedman
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

6.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

7.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

8.  Development of a new method for diagnosis of rubella virus infection by reverse transcription-loop-mediated isothermal amplification.

Authors:  Nobuo Mori; Yoshie Motegi; Yasushi Shimamura; Takashi Ezaki; Tomo Natsumeda; Toshihiro Yonekawa; Yoshinori Ota; Tsugunori Notomi; Tetsuo Nakayama
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients.

Authors:  Dayana Bravo; Beatriz Muñoz-Cobo; Elisa Costa; M Angeles Clari; Nuria Tormo; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

10.  Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity.

Authors:  Christelle Vauloup-Fellous; Jessica Ursulet-Diser; Liliane Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.